Extended Study of NUS1 Gene Variants in Parkinson's Disease

Lamei Yuan, Xiangyu Chen, Zhi Song, Weidong Le, Wen Zheng, Xin Liu, Hao Deng

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


Parkinson's disease (PD), is the second most common neurodegenerative disorder worldwide. Genetic, environmental factors, and aging are its primary development contributors. Recently the nuclear undecaprenyl pyrophosphate synthase 1 homolog (Saccharomyces cerevisiae) gene (NUS1) was reported as a candidate gene for PD, which raised our interest in the relationship between NUS1 and PD. This study was aimed to further explore the role of NUS1 variants in PD development. Genetic analysis for 308 Han-Chinese PD patients and 308 ethnically matched controls using whole exome sequencing was conducted. Additionally, a total of 60 articles involving in whole exome/whole genome sequencing or direct sequencing of the NUS1 gene from PubMed database between July 1, 2011 and August 26, 2020 were reviewed to evaluate PD-associated NUS1 variants. No potentially pathogenic NUS1 variant was found in 308 PD cases, and no frequency biases between 308 PD cases and 308 controls were observed for the only non-synonymous variant p.Asp179Glu (genotype: χ2 = 0.093, P = 0.761; allele: χ2 = 0.092, P = 0.762). No pathogenic or disease-associated NUS1 variant was reported in the 5,636 PD cases of the 60 articles. In summary, current findings indicate that NUS1 variant is not a common genetic factor contributing to PD.

Original languageEnglish (US)
Article number583182
JournalFrontiers in Neurology
StatePublished - Oct 27 2020


  • NUS1
  • Parkinson's disease
  • genetic analysis
  • whole exome sequencing
  • whole genome sequencing

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Extended Study of NUS1 Gene Variants in Parkinson's Disease'. Together they form a unique fingerprint.

Cite this